Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 021695
Company: LUPIN
Company: LUPIN
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
ANTARA (MICRONIZED) | FENOFIBRATE | 43MG | CAPSULE;ORAL | Prescription | AB | Yes | No |
ANTARA (MICRONIZED) | FENOFIBRATE | 87MG | CAPSULE;ORAL | Discontinued | None | No | No |
ANTARA (MICRONIZED) | FENOFIBRATE | 130MG | CAPSULE;ORAL | Prescription | AB | Yes | Yes |
ANTARA (MICRONIZED) | FENOFIBRATE | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL | Discontinued | None | Yes | No |
ANTARA (MICRONIZED) | FENOFIBRATE | 90MG | CAPSULE;ORAL | Discontinued | None | Yes | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
11/30/2004 | ORIG-1 | Approval | Type 3 - New Dosage Form | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021695lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/021695ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021695s000_AntaraTOC.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
06/03/2021 | SUPPL-22 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021695s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/021695Orig1s022ltr.pdf | |
05/15/2019 | SUPPL-20 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021695s020lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021695Orig1s020ltr.pdf | |
11/07/2018 | SUPPL-19 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021695s019lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021695Orig1s019ltr.pdf | |
02/04/2019 | SUPPL-18 |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021695s018lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021695Orig1s018ltr.pdf | ||
05/18/2018 | SUPPL-17 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021695s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021695Orig1s017ltr.pdf | |
09/11/2017 | SUPPL-16 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021695s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/021695Orig1s016ltr.pdf | |
11/29/2016 | SUPPL-14 | Manufacturing (CMC) |
Label is not available on this site. |
||
11/09/2016 | SUPPL-13 | Manufacturing (CMC) |
Label is not available on this site. |
||
08/31/2015 | SUPPL-12 | Manufacturing (CMC) |
Label (PDF)
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021695s012lbl.pdf | |
09/04/2014 | SUPPL-11 | Manufacturing (CMC) |
Label is not available on this site. |
||
12/19/2012 | SUPPL-10 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021695s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021695Orig1s010ltr.pdf | |
10/18/2013 | SUPPL-9 | Manufacturing (CMC) |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021695s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021695Orig1s009ltr.pdf | |
03/01/2012 | SUPPL-8 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021695s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021695s008ltr.pdf | |
06/03/2008 | SUPPL-6 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021695s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021695s006ltr.pdf | |
10/21/2005 | SUPPL-1 | Efficacy-Labeling Change With Clinical Data |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021695s001ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
06/03/2021 | SUPPL-22 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021695s022lbl.pdf | |
05/15/2019 | SUPPL-20 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021695s020lbl.pdf | |
02/04/2019 | SUPPL-18 | Manufacturing (CMC) | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021695s018lbl.pdf | |
11/07/2018 | SUPPL-19 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021695s019lbl.pdf | |
05/18/2018 | SUPPL-17 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021695s017lbl.pdf | |
09/11/2017 | SUPPL-16 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021695s016lbl.pdf | |
08/31/2015 | SUPPL-12 | Manufacturing (CMC) | Label (PDF) | This supplement type does not usually require new labeling. | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021695s012lbl.pdf |
10/18/2013 | SUPPL-9 | Manufacturing (CMC) | Label (PDF) | This supplement type does not usually require new labeling. | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021695s009lbl.pdf |
12/19/2012 | SUPPL-10 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021695s010lbl.pdf | |
03/01/2012 | SUPPL-8 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021695s008lbl.pdf | |
06/03/2008 | SUPPL-6 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021695s006lbl.pdf | |
11/30/2004 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021695lbl.pdf |
ANTARA (MICRONIZED)
CAPSULE;ORAL; 43MG
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
ANTARA (MICRONIZED) | FENOFIBRATE | 43MG | CAPSULE;ORAL | Prescription | Yes | AB | 021695 | LUPIN |
FENOFIBRATE | FENOFIBRATE | 43MG | CAPSULE;ORAL | Prescription | No | AB | 201748 | SUN PHARM INDS LTD |
FENOFIBRATE (MICRONIZED) | FENOFIBRATE | 43MG | CAPSULE;ORAL | Prescription | No | AB | 202252 | APOTEX |
FENOFIBRATE (MICRONIZED) | FENOFIBRATE | 43MG | CAPSULE;ORAL | Prescription | No | AB | 090859 | DR REDDYS LABS SA |
CAPSULE;ORAL; 130MG
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
ANTARA (MICRONIZED) | FENOFIBRATE | 130MG | CAPSULE;ORAL | Prescription | Yes | AB | 021695 | LUPIN |
FENOFIBRATE | FENOFIBRATE | 130MG | CAPSULE;ORAL | Prescription | No | AB | 201748 | SUN PHARM INDS LTD |
FENOFIBRATE (MICRONIZED) | FENOFIBRATE | 130MG | CAPSULE;ORAL | Prescription | No | AB | 202252 | APOTEX |
FENOFIBRATE (MICRONIZED) | FENOFIBRATE | 130MG | CAPSULE;ORAL | Prescription | No | AB | 090859 | DR REDDYS LABS SA |